Market Closed –
Nyse
04:00:00 2025-09-11 pm EDT
2.500 USD
Published on 09/10/2025
at 08:33 am EDT
Reuters
This article is reserved for members Unlock the article: REGISTER NOW!
© Reuters – 2025
Catheter Precision Announces Tender Win and First Purchase Order in Croatia
Catheter Precision announces tender win and first purchase order in Croatia
Catheter Precision announces tender win and first purchase order in Croatia
Catheter Precision, Inc. Announces Introduction of the LockeT Product Line into Italy
Catheter Precision Announces First Procedures in France as LockeT Expansion Continues
Catheter Precision receives notification of new patent issuance for VIVO product line
Catheter Precision, Inc. Receives Notification of New Patent Issuance for VIVO Product Line
Top Premarket Decliners
Catheter Precision Receives UK Approval for Suture Retention Device
Catheter Precision, Inc. Enters into an Additional Agreement with HC21 to Distribute LockeT
Catheter Precision, Inc. Announces First LockeT Cases Completed in Germany
Catheter Precision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
Catheter Precision, Inc. Announces First Purchase Order from University Hospital in Rennes, France
Catheter Precision, Inc. Forms New Joint Venture Called Kardionav to Exploit Patented AI Techniques to Create New VT Software Platform
Catheter Precision Says It Is Unaware Of Reason For Increased Market Activity
Catheter Precision, Inc. Secures VIVO Purchase Order from Sahlgrenska University Hospital
Catheter Precision, Inc. Announces Chief Commercial Officer Changes
Catheter Precision, Inc. Receives Ce Mark for LockeT
Catheter Precision Receives CE Mark Approval for LockeT Vascular Closure Device
Catheter Precision Inc Files For Resale Of Up To 12.9 Million Shares Of Common Stock By The Selling Stockholders – SEC Filing
Catheter Precision Enters At Market Offering Agreement With Ladenburg Thalmann & Co. Inc – SEC Filing
Catheter Precision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
Catheter Precision, Inc. announced that it has received $1.5 million in funding
Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure
Catheter Precision Reports ‘Going Concern’ Notice in Recent Annual Report
DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.
PeriodDayWeek
Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
OUR EXPERTS ARE HERE FOR YOU
Monday – Friday 9am-12pm / 2pm-6pm GMT + 1
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
Select your edition
All financial news and data tailored to specific country editions